Evidence map›Paper›PMID 34658687›Full record

ArticleApplied soft computing2021

An evolvable adversarial network with gradient penalty for COVID-19 infection segmentation.

Juanjuan He, Qi Zhu, Kai Zhang, Piaoyao Yu, Jinshan Tang

Open access · greenAbstract read
In one paragraph

Article in Applied soft computing, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Juanjuan HeCollege of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, China.
Qi ZhuCollege of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, China.
Kai ZhangCollege of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, China.
Piaoyao YuCollege of Computer Science and Technology, Wuhan University of Science and Technology, Wuhan, China.
Jinshan TangDepartment of Health Administration and Policy George Mason University, Fairfax, VA, 22030, USA.
Wuhan University of Science and Technology · CNGeorge Mason University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 infection segmentation has essential applications in determining the severity of a COVID-19 patient and can provide a necessary basis for doctors to adopt a treatment scheme. However, in clinical applications, infection segmentation is performed by human beings, which is time-consuming and generally introduces bias. In this paper, we developed a novel evolvable adversarial framework for COVID-19 infection segmentation. Three generator networks compose an evolutionary population to accommodate the current discriminator, i.e., generator networks evolved with different mutations instead of the single adversarial objective to provide sufficient gradient feedback. Compared with the existing work that enforces a Lipschitz constraint by weight clipping, which may lead to gradient exploding or vanishing, the proposed model also incorporates the gradient penalty into the network, penalizing the discriminator's gradient norm input. Experiments on several COVID-19 CT scan datasets verified that the proposed method achieved superior effectiveness and stability for COVID-19 infection segmentation.

Indexed as

COVID-19Evolutionary algorithmGradient penaltyInfection segmentationWasserstein generative adversarial network

Identifiers

PMID34658687
PMCPMC8507576
OpenAlexW3206394563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.